India to Burundi Pharmaceutical Export
Bilateral Trade Intelligence · $17.2M Total Trade · 140 Exporters · 147 Buyers · DGFT Verified · Updated March 2026
India exported $17.2M worth of pharmaceutical formulations to Burundi across 2,681 verified shipments, sourced from 140 Indian exporters supplying 147 Burundi buyers. The top exporters are MACLEODS PHARMACEUTICALS LTD ($7.1M) and CIPLA LIMITED ($1.1M). The leading products are Ethambutol ($3.5M) and Artemether ($358K). Average shipment value: $6.4K.
Top Pharmaceutical Formulations — India to Burundi
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Ethambutol Dispersible Tablets 100 MG Bno:nee2309b/nee2311a/nee2310a Md.05/23 E… | $3.5M | 20.5% |
| 2 | Drugs and Pharmaceuticals Harmless Medicines, Dolutegravir Sodium 10mg Dispersi… | $3.3M | 18.9% |
| 3 | Artemether/lumefantrine 20mg/120mg Tbs 30 Blisters of 24 Tbs (artemether+lumefa… | $507.6K | 2.9% |
| 4 | Dolutegravir (as Sodium) + Lamivudine + Tenofovir Disoproxil Fumarate Tablets 5… | $491.0K | 2.9% |
| 5 | Easy Five Tt Vaccine Dtwp-hepb-hib Penta | $411.5K | 2.4% |
| 6 | Amoxicillin Capsules BP 500 MG ( =1,11,90,000 Capsules) (qty of Amoxicillin Tri… | $251.8K | 1.5% |
| 7 | Amoxicillin Capsules BP 500 MG ( =111,90,000 Capsules) (qty of Amoxicillin Trih… | $251.8K | 1.5% |
| 8 | Dtp-hepb-hib (pentavalent Vaccine) Fullyliquid Combination Vaccine 10 Dose Vial… | $241.2K | 1.4% |
| 9 | Dtp-hepb-hib (pentavalent Vaccine) Fullyliquid Combination Vaccine, 10 Dose (5m… | $235.4K | 1.4% |
| 10 | Dolutegravir Lamivudine and Tenofovir | $231.3K | 1.3% |
| 11 | Artemether/lumefantrine 20mg/120mg Dispersible Tbs -lumerax Dt 20/120 (artemeth… | $207.0K | 1.2% |
| 12 | Dolutegravir (as Sodium)+lamivudine+tenofovir Disoproxil Fumarate Tablets 50/30… | $196.8K | 1.1% |
| 13 | Abacavir (as Sulfate) and Lamivudinedis | $111.5K | 0.6% |
| 14 | Drugs and Pharmaceuticals Harmless Medicines:lumiter Dt | $105.9K | 0.6% |
| 15 | 4 Fdc Tablets USP Undp (rifampicin 150mg+isoniazid 75mg+pyrazinamide 400mg+etha… | $97.9K | 0.6% |
India exports 17+ pharmaceutical formulations to Burundi with a combined trade value of $17.2M. Key products include Ethambutol ($3.5M), Artemether ($358K), Dolutegravir ($295K), Amoxicillin ($252K), Sodium ($196K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 2,681 verified Indian Customs (DGFT) shipment records.
Top Pharmaceutical Products — India to Burundi Trade Routes
These are the top pharmaceutical products exported from India to Burundi, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Burundi buyers, regulatory requirements, and logistics for that specific product corridor. Products include Ethambutol ($3.5M), Artemether ($358K), Dolutegravir ($295K), Amoxicillin ($252K), Sodium ($196K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
Top Indian Exporters to Burundi
140 Indian pharmaceutical companies export finished formulations to Burundi. Leading exporters include Macleods Pharmaceuticals Ltd, Cipla Limited, Grandeur Pharma Private Limited, Ipca Laboratories Limited. The top exporter accounts for 41.1% of total India–Burundi pharma exports. Source: Indian Customs (DGFT).
Top Burundi Buyers from India
147 companies in Burundi import pharmaceutical formulations from India. Top buyers include Undp Office In Burundi, Chemonics International (burundi, Motley Healthcare Sprl, Programme Des Nations Unies (pnud). The largest buyer accounts for 21.1% of India–Burundi pharma imports. Source: Indian Customs (DGFT).
Port Analysis — India to Burundi Pharmaceutical Shipments
Indian Export Ports
Burundi Import Ports
Trade Statistics
Other Destinations
Product Routes
India–Burundi Pharmaceutical Trade Corridor Analysis
Historical evolution, India's market position, and recent developments
1Trade Corridor Evolution
The pharmaceutical trade between India and Burundi has experienced significant growth over the past decade. In 2023, Burundi imported pharmaceutical products valued at $19.15 million from India, marking a substantial increase from previous years. This upward trajectory reflects India's expanding role as a key supplier of essential medicines to Burundi.
The trade is characterized by a diverse range of products, with the top ten items accounting for approximately 48% of the total export value. Notably, antiretroviral drugs such as Dolutegravir Sodium 10mg Dispersible Tablets and combination therapies like Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate Tablets are among the leading exports. This indicates a strong alignment with Burundi's healthcare priorities, particularly in the treatment of HIV/AIDS.
2India's Market Position
India's pharmaceutical exports to Burundi have solidified its position as a dominant supplier in the region. In 2023, pharmaceutical products constituted a significant portion of India's total exports to Burundi, underscoring the strategic importance of this corridor. The consistent growth in export value and the diversification of products suggest a robust and expanding market presence.
While specific data on Burundi's total pharmaceutical imports from all sources is limited, India's substantial share indicates a strong competitive edge. The presence of multiple Indian exporters, including major companies like Macleods Pharmaceuticals Ltd., Cipla Limited, and Ipca Laboratories Limited, further reinforces India's market dominance.
3Recent Developments
Between 2024 and 2026, the India-Burundi pharmaceutical trade corridor has witnessed continued growth, with exports reaching $12.30 million in 2024. This upward trend reflects the strengthening of bilateral trade relations and India's commitment to supporting Burundi's healthcare sector.
While specific bilateral trade agreements or diplomatic visits directly impacting pharmaceutical trade during this period are not detailed in the available sources, the sustained growth and diversification of products suggest ongoing collaborative efforts. The active participation of Indian pharmaceutical companies in exporting to Burundi indicates a favorable business environment and a commitment to meeting the healthcare needs of the Burundian population.
FAQ — India to Burundi Pharmaceutical Trade
What is the total value of India's pharmaceutical export to Burundi?
India exported pharmaceuticals worth $17.2M to Burundi across 2,681 verified shipments.
Who are the top Indian pharmaceutical exporters to Burundi?
1. MACLEODS PHARMACEUTICALS LTD — $7.1M. 2. CIPLA LIMITED — $1.1M. 3. GRANDEUR PHARMA PRIVATE LIMITED — $989.9K. Total: 140 suppliers.
Which companies in Burundi import pharmaceuticals from India?
1. UNDP OFFICE IN BURUNDI — $3.6M. 2. CHEMONICS INTERNATIONAL (BURUNDI — $3.3M. 3. MOTLEY HEALTHCARE SPRL — $1.2M. 147 buyers total.
What pharmaceutical products does India export most to Burundi?
1. Ethambutol Dispersible Tablets 100 MG Bno:nee2309b/nee2311a/nee2310a Md.05/23 E… ($3.5M, 20.5%); 2. Drugs and Pharmaceuticals Harmless Medicines, Dolutegravir Sodium 10mg Dispersi… ($3.3M, 18.9%); 3. Artemether/lumefantrine 20mg/120mg Tbs 30 Blisters of 24 Tbs (artemether+lumefa… ($507.6K, 2.9%); 4. Dolutegravir (as Sodium) + Lamivudine + Tenofovir Disoproxil Fumarate Tablets 5… ($491.0K, 2.9%); 5. Easy Five Tt Vaccine Dtwp-hepb-hib Penta ($411.5K, 2.4%)
Which ports handle pharmaceutical shipments from India to Burundi?
Export: STARTRACK TERMINAL ICD, LCS JAIGAON, NHAVA SHEVA SEA (INNSA1), SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4). Import: BUJUMBURA, Dar Es Salaam, Bujumbura, DAR ES SALAAM, Gitega.
Why does Burundi import pharmaceuticals from India?
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $17.2M corridor reflects quality compliance and pricing advantages.
What certifications do Indian pharmaceutical exporters need to supply Burundi?
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
What is the average shipment value for India to Burundi pharmaceutical trade?
$6.4K per consignment across 2,681 shipments.
How many Indian pharmaceutical companies export to Burundi?
140 Indian companies. Largest: MACLEODS PHARMACEUTICALS LTD with $7.1M.
How can I find verified Indian pharmaceutical suppliers for Burundi?
TransData Nexus covers 140 active exporters with shipment history and trade values at transdatanexus.com.
Unlock the Full India to Burundi Pharmaceutical Export Dataset
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 2,681 shipments.
Official References & Regulatory Resources
- WHO Essential Medicines List
- CDSCO India
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
- 2.Country Matching: Shipments to Burundi identified using destination country codes from customs declarations.
- 3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
- 4.Coverage: 2,681 verified shipments from 140 Indian exporters to 147 Burundi buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
140 Exporters
147 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists